Chemoinformaics analysis of 4-ISOPROPYLSALICYLALDEHYDE
| Molecular Weight | 164.204 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 7 |
| Exact Molecular Weight | 164.084 | nRing | 1 |
| Solubility: LogS | -2.842 | nHRing | 0 |
| Solubility: LogP | 3.018 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 26.3055 |
| nHD | 1 | BPOL | 12.9065 |
| QED | 0.681 |
| Synth | 2.129 |
| Natural Product Likeliness | 0.586 |
| NR-PPAR-gamma | 0.274 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.015 |
| HIA | 0.004 |
| CACO-2 | -4.437 |
| MDCK | 0.0000195 |
| BBB | 0.878 |
| PPB | 0.882142 |
| VDSS | 1.207 |
| FU | 0.0967917 |
| CYP1A2-inh | 0.947 |
| CYP1A2-sub | 0.739 |
| CYP2c19-inh | 0.439 |
| CYP2c19-sub | 0.474 |
| CYP2c9-inh | 0.397 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.339 |
| CYP2d6-sub | 0.535 |
| CYP3a4-inh | 0.162 |
| CYP3a4-sub | 0.291 |
| CL | 3.374 |
| T12 | 0.608 |
| hERG | 0.011 |
| Ames | 0.188 |
| ROA | 0.054 |
| SkinSen | 0.321 |
| Carcinogencity | 0.414 |
| EI | 0.991 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.886062 |